Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,960 | 3,610 | 10,510 | 8,760 | 3,330 |
| Receivables | 75,650 | 69,900 | 67,530 | 61,010 | 59,630 |
| Inventories | 19,000 | 13,850 | 12,470 | 12,520 | 10,100 |
| Other current assets | 17,760 | 9,900 | 7,160 | 5,890 | 8,540 |
| TOTAL | $120,370 | $97,260 | $97,670 | $88,180 | $81,600 |
| Non-Current Assets | |||||
| PPE Net | 79,840 | 72,830 | 69,680 | 63,880 | 62,370 |
| Investments And Advances | 1,790 | 2,170 | 1,180 | 2,090 | 1,160 |
| Other Non-Current Assets | 140,680 | 85,290 | 85,590 | 85,720 | 86,410 |
| TOTAL | $222,310 | $160,290 | $156,450 | $151,690 | $149,940 |
| Total Assets | $321,900 | $239,170 | $238,010 | $227,660 | $221,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,740 | 1,150 | 3,070 | 1,340 | 1,070 |
| Accounts payable and accrued liabilities | 26,840 | 13,130 | 14,150 | 12,860 | 12,410 |
| Accrued Expenses | 25,060 | 22,430 | 16,450 | 33,510 | 31,860 |
| Other current liabilities | 950 | 2,060 | 2,250 | 0 | 0 |
| TOTAL | $58,870 | $39,170 | $42,090 | $50,170 | $48,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69,900 | 70,700 | 70,620 | 111,490 | 110,930 |
| Other Non-Current Liabilities | 23,790 | 10,650 | 6,220 | 7,500 | 7,840 |
| TOTAL | $93,690 | $81,350 | $81,790 | $120,400 | $120,150 |
| Total Liabilities | $152,570 | $120,530 | $123,900 | $170,600 | $168,470 |
| Shareholders' Equity | |||||
| Common Shares | 460 | 420 | 420 | 180 | 180 |
| Retained earnings | 33,830 | 31,110 | 26,860 | 21,190 | 16,860 |
| Other shareholders' equity | 10 | 20 | 10 | 10 | 10 |
| TOTAL | $169,320 | $118,640 | $114,110 | $57,060 | $52,590 |
| Total Liabilities And Equity | $321,890 | $239,170 | $238,010 | $227,660 | $221,060 |